# Precision Optics Corporation, Inc. (POCI) · Edgar & Edgarette company card

> Precision Optics Corporation (POCI) grew revenue 65.2% in FY2026 to $32 million, operating margin -11.1% against a 7.5% median for electromedical & electrotherapeutic apparatus, equity 62.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 867840 · fiscal year ended 2026-06-30 · 5 audited years read · [page](https://www.pops4.com/boards/company/POCI) · [JSON](https://www.pops4.com/boards/company/POCI.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $32M |
| Revenue growth, 1 year | 65.2% |
| Revenue growth per year | 19.1% |
| Operating margin | -11.1% (prior year -29.1%) |
| Net margin | -11.5% |
| Operating cash flow | −$2M |
| Capital spending | $426,786 |
| Free cash flow | −$2M |
| Cash | $10M |
| Long-term debt | $1M |
| Total assets | $32M |
| Total equity | $20M |
| Equity ÷ assets | 62.9% |
| Return on equity | -17.8% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -2.77 (distress zone)
- Piotroski F: 5 of 9 (middling)
- Beneish M: -2.28 (below the −1.78 line)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative; revenue is hard to predict: its 80% range is ±47%
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $31.5M (FY2026), total debt $1.3M. Experience: revenue up 65.2% on the year, up 19.1% a year over 4 years; operating margin -11.1%, up from -29.1%. Soundness: equity 62.9% of assets, return on equity -17.8%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $25.9M and $72.0M next year (method v4.1: its own 6-year record of growth weighed at 63% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $24.2M to $77.5M. A statistical range, not company guidance. Against peers (13 filers, $50M+ revenue, electromedical & electrotherapeutic apparatus): operating margin -11.1% against a 7.5% median; growth 65.2% against 8.3%.

Range logged 2026-10-28, receipt d2e2a67f25150a82, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

No warning filings in the window.

## Recent filings

- DEF 14A · filed 2026-10-27 · [filing](https://www.sec.gov/Archives/edgar/data/867840/000168316826008117/0001683168-26-008117-index.htm)
- 8-K · filed 2026-09-28 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/867840/000168316826007465/0001683168-26-007465-index.htm)
- 10-K · filed 2026-09-28 · [filing](https://www.sec.gov/Archives/edgar/data/867840/000168316826007462/0001683168-26-007462-index.htm)
- 10-Q · filed 2026-05-13 · [filing](https://www.sec.gov/Archives/edgar/data/867840/000168316826003818/0001683168-26-003818-index.htm)
- 8-K · filed 2026-03-30 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/867840/000168316826002421/0001683168-26-002421-index.htm)
- 8-K · filed 2026-03-20 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/867840/000168316826002057/0001683168-26-002057-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000867840.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=867840

## Cite

POPS4, Edgar & Edgarette: Precision Optics Corporation, Inc. (POCI) company card, from the company's own SEC filings, accessed 2026-10-28, https://www.pops4.com/boards/company/POCI. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.